Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jonas B Olesen"'
Autor:
Jarl E. Strange, Emil L. Fosbøl, Caroline Sindet-Pedersen, Eva Havers-Borgersen, Lars Køber, Gunnar H. Gislason, Jonas B. Olesen
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 43, Iss , Pp 101157- (2022)
Background: Of patients undergoing transcatheter aortic valve replacement (TAVR), 80–90 % are at extreme, high, or intermediate risk. Patient selection considering futile outcomes in these groups is difficult as significant comorbidity burden is co
Externí odkaz:
https://doaj.org/article/8727b526a190439685d210de91adec60
Autor:
Naja E. Vinding, Jawad H. Butt, Jonas B. Olesen, Ying Xian, Søren Lund Kristensen, Rasmus Rørth, Anders Nissen Bonde, Anna Gundlund, Adelina Yafasova, Peter E. Weeke, Gunnar H. Gislason, Christian Torp‐Pedersen, Lars Køber, Emil L. Fosbøl
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 6 (2022)
Background Oral anticoagulation (OAC) is effective for stroke prevention in patients with atrial fibrillation. However, some patients experience stroke despite OAC therapy, and knowledge about the impact of prior treatment quality is lacking. Methods
Externí odkaz:
https://doaj.org/article/b6aee8da33004843babc0546fa50a8fb
Autor:
Naja E. Vinding, Søren L. Kristensen, Rasmus Rørth, Jawad H. Butt, Lauge Østergaard, Jonas B. Olesen, Christian Torp‐Pedersen, Gunnar H. Gislason, Lars Køber, Christina Kruuse, Søren P. Johnsen, Emil L. Fosbøl
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 4 (2022)
Background Our objective was to investigate stroke severity and subsequent rate of mortality among patients with and without atrial fibrillation (AF). Contemporary data on stroke severity and prognosis in patients with AF are lacking. Methods and Res
Externí odkaz:
https://doaj.org/article/2cee6de5cc294445817f6482b7e5d8c5
Autor:
Jarl E. Strange, Caroline Sindet-Pedersen, Anders Holt, Mikkel P. Andersen, Christian Torp-Pedersen, Lars Køber, Gunnar H. Gislason, Jonas B. Olesen, Emil L. Fosbøl
Publikováno v:
JACC: Cardiovascular Interventions. 16:179-188
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c65fb666621164bcf2ad03041ad964a2
https://doi.org/10.1016/j.jcin.2022.10.051
https://doi.org/10.1016/j.jcin.2022.10.051
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 7, Iss C, Pp 18-21 (2015)
Background: With the publication of the 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation, the Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee has introduced a new
Externí odkaz:
https://doaj.org/article/a4cbd16cdf2b46608131d39bc45c8be9
Autor:
Nicholas, Carlson, Kristine, Hommel, Jonas B, Olesen, Thomas A, Gerds, Anne-Merete, Soja, Tina, Vilsbøll, Anne-Lise, Kamper, Christian, Torp-Pedersen, Gunnar, Gislason
Publikováno v:
Diabetes, obesitymetabolism. 18(12)
Recent guidelines governing anti-diabetic medications increasingly advocate metformin as first-line therapy in all patients with type 2 diabetes. However, metformin could be associated with increased risk of acute kidney injury (AKI), acute dialysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::65d38bc5aca9a6342beeaf9237a2e670
https://pubmed.ncbi.nlm.nih.gov/27585960
https://pubmed.ncbi.nlm.nih.gov/27585960
Publikováno v:
Journal of the American College of Cardiology. 66(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7edb230052de5cf6b3621ceb9e026db2
https://pubmed.ncbi.nlm.nih.gov/26361166
https://pubmed.ncbi.nlm.nih.gov/26361166
Autor:
Amitava Banerjee, Sophie Taillandier, Jonas B Olesen, Deirdre A Lane, Benedicte Lallemand, Gregory Y Lip, Laurent Fauchier
Publikováno v:
Circulation. 125
Background: The risk of stroke and thromboembolism (TE) in patients with non-valvular atrial fibrillation (NVAF) can be classified in commonly-used stroke risk stratification scores. The role of the pattern of atrial fibrillation in risk prediction i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af5d1fc9335edc8fbade3da6fc37c375
https://doi.org/10.1161/circ.125.suppl_10.ap285
https://doi.org/10.1161/circ.125.suppl_10.ap285
Autor:
Laurent Fauchier, Sophie Taillandier, Dominique Babuty, Jonas B. Olesen, Isabelle Lagrenade, Nicolas Clémenty, Gregory Y. H. Lip
Publikováno v:
Journal of cardiovascular electrophysiology. 23(7)
Stroke and CHA2DS2-VASc Score = 0. Objectives: Patients with atrial fibrillation (AF) and a CHA2DS2-VASc score = 0 have a very low risk of stroke and current guidelines even recommend no antithrombotic therapy to these patients. We investigated the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7df05c1e2262756aefcfd5847094ff44
https://pubmed.ncbi.nlm.nih.gov/22313332
https://pubmed.ncbi.nlm.nih.gov/22313332
Autor:
Jonas B, Olesen, Gunnar H, Gislason, Mette G, Charlot, Emil L, Fosbøl, Charlotte, Andersson, Peter, Weeke, Ole, Ahlehoff, Christian, Selmer, Christian, Torp-Pedersen, Peter R, Hansen
Publikováno v:
Journal of the American College of Cardiology. 57(4)
The purpose of this study was to determine the risk of adverse cardiovascular events associated with concomitant use of clopidogrel and calcium-channel blockers (CCBs) in patients with myocardial infarction (MI).CCBs inhibit a variety of cytochrome P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5b16b429e17ee0d17bf282539114ea5
https://pubmed.ncbi.nlm.nih.gov/21251580
https://pubmed.ncbi.nlm.nih.gov/21251580